Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q3 2026Earnings call Nov 4, 2026 · most recent call
CRL’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Charles River Laboratories’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: CRL daily prices (open, high, low, close) with a 50-day moving average; lines mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
No 8-K events recorded since this call day.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $1.00B | -1.1% | -$4.22 | -216.6% | -16.7% | -21.4% | $84M |
| FY2025 Q1 | $984M | -2.7% | $0.50 | -61.5% | 7.6% | 2.6% | $112M |
| FY2025 Q2 | $1.03B | +0.6% | $1.06 | -39.1% | 9.7% | 5.1% | $169M |
| FY2025 Q3 | $1.00B | -0.5% | $1.10 | -17.3% | 13.3% | 5.4% | $178M |
| FY2025 Q4 | $994M | -0.8% | -$5.62 | n/m | -28.5% | -27.8% | $59M |
| FY2026 Q1 | $996M | +1.2% | -$0.30 | -160.0% | 12.0% | -1.5% | -$15M |
| FY2026 Q2 | $1.00B | -2.7% | -$0.03 | -102.8% | 11.9% | -0.1% | $149M |
| FY2026 Q3Selected | $983M | -2.2% | $6.86 | +523.6% | 20.6% | 33.9% | $207M |
FY2025 Q4: Prior-year quarter was a loss (-$4.22 EPS), so a percent change isn't meaningful.
Management-stated figures from CRL’s newest call are part of Tellvest Pro.